Invex Therapeutics has received a $5 million investment from Andrew Forrest’s Tattarang as part of a share placement, with the proceeds to go towards the company’s research into neurological diseases.
Invex raises $26m for clinical trials
22/05/2020 - 11:16
Related Data & Insights
-
Invex TherapeuticsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 175th Invex Therapeutics $459k 191st Pura Vida Energy $74k 192nd Connected IO $24k 194th 4DS Memory $0 195th HearMeOut $0 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned People
Related Articles
08 Apr 2024
Bree Fraser launches advisory firm
05 Apr 2024
Mark My Words podcast April 5 2024
13 Mar 2024
Arrow to raise $10m
05 Mar 2024
Peppermint raises $1.1m amid loss
19 Feb 2024
Hazer taps investors for $9m
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX